Search

Blood Group Typing Market - Global Size, Share, Trends, Growth and Forecast Year ( 2023 – 2032 )

Healthcare & Pharmaceutical

Request PDF Sample Request Discount
  • Status : Published
  • Published on: April 2023
  • Report ID: KDMI-7168
  • Available Format: PDF/Excel/DOC

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Blood Group Typing Market

Request PDF Sample

Blood Group Typing

Blood group typing is a laboratory test that is used to determine an individual's blood type. The test is typically performed on a sample of blood and is used to identify the presence of certain antigens and antibodies in the blood. There are four major blood groups: A, B, AB, and O. Each blood group is determined by the presence or absence of certain antigens on the surface of red blood cells. Blood group typing is used in a variety of settings, including hospitals, blood banks, and research laboratories. It is an important test for transfusion medicine as it helps in matching blood donors and recipients.


Blood Group Typing Market

The market size for the Blood Group Typing Market was USD 1.9 billion in the year 2022. It is expected that the market size for Blood Group Typing will increase by approximately USD 4.9 billion by 2032 as the market for Blood Group Typing is continuously growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period 2023-2032. The blood group typing market is a subset of the broader in-vitro diagnostics (IVD) market. The market is driven by factors such as the increasing incidence of chronic diseases and the growing demand for blood transfusions.


 Blood Group Typing Market Report Scope

Base Year

Market Size

2022

USD 1.9 billion

 

Forecast Year

Market Size

 

2032

USD 4.9 billion

CAGR Value

 

9.5% from 2023 to 2032

Segmentation

 

  • By product
  • By application
  • By end-user
  • By geography

 

Challenges

 

  • Lack of standardization
  • High cost
  • Limited availability in developing countries
  • Limited reimbursement
  • Quality control issues

Growth Drivers

 

  • Increasing incidence of chronic diseases
  • Growing demand for blood transfusions
  • Increasing number of surgical procedures
  • Growing number of blood donation camps
  • Advancements in technology
  • Increasing awareness about the importance of blood typing

Blood Group Typing Market Key Drivers

There are various factors which help in the growth of the Blood Group Typing Market. They are as follows:

  • Increasing incidence of chronic diseases: The growing prevalence of chronic diseases such as cancer, diabetes, and heart disease is leading to a higher demand for blood transfusions.
  • Growing demand for blood transfusions: Blood transfusions are becoming increasingly common in hospitals and other healthcare settings, which is driving demand for blood group typing.
  • Increasing number of surgical procedures: The rising number of surgical procedures, such as organ transplants, is also driving demand for blood group typing.
  • Growing number of blood donation camps: Blood donation camps are becoming increasingly common, which is leading to a higher demand for blood group typing.
  • Advancements in technology: There are technological advancements taking place in blood group typing, such as PCR-based and next-generation sequencing, which is driving the market.
  • Increasing awareness about the importance of blood typing: People are getting more aware of blood typing, which is increasing the market demand.
  • Government support and funding for blood banks and blood typing centers
  • Rising geriatric population and an increasing number of blood disorders such as anemia and thalassemia.

Blood Group Typing Market Challenges

There are many challenges which are faced by Blood Group Typing Market. They are listed below:

  • Lack of standardization: The lack of standardization in blood group typing methods and protocols can lead to incorrect results and difficulties in comparing data.
  • High cost: Advanced technologies for blood typing can be expensive, which can be a barrier for some patients.
  • Limited availability in developing countries: Blood typing is available in limited developing countries, which limits its access for patients.
  • Shortage of blood supply: The shortage of blood is a major concern as there is a lack of blood donation in some countries, which may act as a challenge.
  • Limited reimbursement: Blood typing is not reimbursed by some healthcare providers and insurance companies, which may limit its access for patients.
  • Quality control issues: Maintaining the quality of reagents and equipment used in blood group typing is a challenge.
  • Lack of skilled workforce: The lack of skilled workforce in many countries for blood group typing can lead to errors in test results and difficulties in interpreting data.
  • Inaccurate results: Inaccurate results of blood group typing can lead to serious complications, which may act as a barrier.

Blood Group Typing Market Segmentation

The Blood Group Typing Market is segmented into various categories which are listed below:

By product:

  • Instruments
  • Reagents
  • Software

By application:

  • Transfusion medicine
  • Prenatal testing
  • Transplantation
  • Research

By end-user:

  • Hospitals
  • Blood banks
  • Research laboratories

By geography:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Blood Group Typing Market - Infographic 


Blood Group Typing Market Key Players

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • BioMérieux SA
  • Hoffmann-La Roche Ltd.
  • Grifols, S.A.
  • Immucor, Inc.
  • Ortho Clinical Diagnostics
  • Quotient Limited
  • Others

FAQ

Blood group typing is a research center test that is utilized to decide a singular's blood classification. The test is regularly performed on an example of blood and is utilized to recognize the presence of specific antigens and antibodies in the blood.

The four major blood groups are: A, B, AB, and O. Each blood group is determined by the presence or absence of certain antigens on the surface of red blood cells.

Blood group typing is used in a variety of settings including hospitals, blood banks, and research laboratories. It is an important test for transfusion medicine as it helps in matching blood donors and recipients.

The driving elements of the blood group typing market incorporate expanding frequency of ongoing sicknesses, growing demand for blood transfusions, expanding number of surgeries, development of several blood donation camps, progressions in innovation, and expanding mindfulness about the significance of blood typing.

The difficulties confronting the blood group typing market incorporate the absence of normalization, significant expense, restricted accessibility in agricultural nations, restricted repayment, and quality control issues.

Some key players in the blood group typing market include Thermo Fisher Scientific Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Danaher Corporation, bioMérieux SA, F. Hoffmann-La Roche Ltd, Grifols, S.A., Immucor, Inc., Ortho Clinical Diagnostics, and Quotient Limited.

Custom Research Requirement? Questions to ask?

Get in touch

Custom Research requirement.

Go Up